Using a cut-off value of 2.421 ng/ml, the sensitivity, specificity, PPV, and NPV for TIMP-2 in the diagnosis of lung cancer were 62.5%, 57.5%, 63.8%, and 56.1%, respectively. Here, TIMP2 is linked to lung carcinoma.